All News

From proposed transparency rules to Medicare price negotiation programs, the stakes are high for pharmacy reimbursement and the sustainability of independent practices.

Annie Lambert, PharmD, BCSCP, discusses the key approaches to ensuring safe and effective dispensing of compounded GLP-1 medications.

Mark Cuban Cost Plus Drug Company challenges pharmacy benefit managers' opacity, expands affordable drug access, and supports community pharmacies.

Harps pharmacists reveal how smart workflow powers point‑of‑care testing, prescribing, and billing—scalable clinical services for regional chains.

Lani Bertrand, senior director of clinical marketing & thought leadership at Omnicell, discusses the consistent drivers of drug shortages in the US.

Matt Sample from Cencora discusses current DSCSA developments on the rise for pharmacy businesses in 2026—namely small dispensers that have been under exemption.

Pharmacists lead safer postsurgical pain care, using multimodal nonopioid options and tight opioid stewardship from pre-operation through home.

Pharmacies expand care with vaccines and birth control services—learn scope, billing tips, and tools to win younger, convenience-driven patients.

Jeff Goad, PharmD, MPH, president of the NFID, discusses the nuances behind COVID-19 vaccine updates and what it can mean for patients and pharmacies alike.

Buchanan Ingersoll & Rooney’s Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, provide a timely legal update regarding GLP-1 distribution and compounding.

As shrinking dispensing margins make it harder for pharmacies to keep their doors open on prescriptions alone, many are turning to clinical services as a lifeline.

Timothy Aungst, PharmD; Ravi Patel, PharmD, MBA, MS; and Smit Patel, PharmD, share their insights on the emerging direct-to-patient pharmacy model.

Pharmacists push for provider status and PBM overhaul as IRA policies squeeze pharmacies—what it means for access to vaccines, PrEP, and vital meds.

If signed by President Trump in time to avoid a government shutdown, HR 7148 has potential to enforce significant change in the prescription drug supply chain.

Community pharmacies continue to operate in unchartered territory regarding Medicare drug price negotiations as the new IRA statute becomes an unavoidable reality for business operations.

Alyssa Billingsley, PharmD, discusses the FDA’s prescription to over-the-counter drug development process and what it means for patients and pharmacies.

PQA releases the SDOH Resource Companion Guide, highlighting successful partnerships and strategies to address health-related social needs effectively.

Consultant pharmacists enhance long-term care by integrating vaccination strategies, educating staff, and addressing the unique needs of older adults.

Buchanan Ingersoll & Rooney’s Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, explore the evolving world of PBMs within the supply chain as well as the role of state boards of pharmacy.

Representatives from the American Society of Consultant Pharmacists joined Drug Topics to discuss the day 1 reality of the Medicare Drug Price Negotiation Program.

President of the Pennsylvania Pharmacists Association, John DeJames, shared his organization’s goals for advancing the pharmacy profession.

Mark Ciarlone, PharmD, business development manager at Liberty Software, discusses pharmacy management systems that drive results.

Outcomes’ Jon Carlson and Nic Bernabe discuss PillCount, Rx30, and the technology making a difference behind community pharmacy counters—among many other pharmacy solutions.

Meagan Brown, PharmD, BCACP, discusses her career journey in various pharmacy roles during National Pharmacist Day, January 12.

In part 3 of our interview with Susan Thomas, RN, she focused on the pharmacist’s role in her organization’s creation of a newly launched women’s health benefit program.

Susan Thomas, RN, joined Drug Topics to discuss current gaps in women’s health and how pharmacists are stepping in to counsel in this space more than ever before.

In part 3 of our interview, Jennifer Flynn, CPHRM, flips the script on potential harms in using social media and explores how pharmacists can use it to advance their career.

Jennifer Flynn, CPHRM, vice president of health care risk management at the Healthcare Provider Service Organization, discusses pharmacists’ roles in patient privacy.